Journal of Neurology & Neurophysiology

Articles published in Journal of Neurology & Neurophysiology have been cited by esteemed scholars and scientists all around the world.

Wens I, Keytsman C, Deckx N, Cools N, Dalgas U, et al. (2016) Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training. European journal of neurology 23: 1028-1035.

Bird J (2016) Quantitative Functional Magnetic Resonance Imaging of Multiple Sclerosis (Doctoral dissertation, University of Calgary).

Kurna VK. Research & Reviews: Journal of Medical and Health Sciences. safety.;23:24.

Guptill JT, Raja SM, Boakye‐Agyeman F, Noveck R, Ramey S, et al. (2016) Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN‐105 in Healthy Adult Subjects. The Journal of Clinical Pharmacology.

Tu TM, Kolls BJ, Soderblom EJ, Cantillana V, Ferrell PD, et al. (2017) Apolipoprotein E mimetic peptide, CN‐105, improves outcomes in ischemic stroke. Annals of Clinical and Translational Neurology.

Safina D, Schlitt F, Romeo R, Pflanzner T, Pietrzik CU, et al. (2016) Low‐density lipoprotein receptor‐related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation. Glia 64:1363-1380.

Janzen W, Warren S, Hector F, Fenrich F, Warren KG (2014) The relationship between geomagnetic disturbances and multiple sclerosis at the edge of the auroral zone. Epidemiol 4: 2161-1165.

Machado Rivero MO (2016) Propuesta de indicadores para la evaluación de la calidad de los Servicios de Información de Medicamentos (Doctoral dissertation, Universidad de Granada (España)).

López Núñez JD (2014) Estudio bibliométrico sobre “Servicios de Información de Medicamentos” en Scopus y Web of Science durante el período 2000–2013 (Doctoral dissertation, Universidad Central" Marta Abreu" de Las Villas).

Machado Rivero MO, Pinto Molina M, Manso Rodríguez RA (2015) RECOSIM: metodología para la resolución de consultas dentro del Servicio de Información sobre Medicamentos. Revista Cubana de Farmacia 49: 322-336.

Rojo GH (2014) Estudio bibliométrico de la Revista Cubana de Farmacia en el período 1995-2013 (Doctoral dissertation, Universidad Central" Marta Abreu" de Las Villas).

Totaro R, Di Carmine C, Marini C, Carolei A (2016) Tumefactive demyelinating lesions: spectrum of disease, diagnosis and treatment. Current Neurobiology 7.

Totaro R, Di Carmine C, Splendiani A, Torlone S, Patriarca L, et al. (2016) Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis. Neurological Sciences 37: 1113-1117.

Boangher S, Goffette S, Van Pesch V, Mespouille P (2016) Early relapse with tumefactive MS lesion upon initiation of fingolimod therapy. Acta Neurologica Belgica 116: 95-97.

Chandra A, Xu YM (2016) Cholesterol: A necessary evil from a multiple sclerosis perspective. Clinical and Experimental Neuroimmunology 7: 145-157.

Junnila SK (2016) Inhaled tiny mica flakes and vitamin B12 intercalated clay dust induce multiple sclerosis. Journal of Epidemiological Research 2: p102.

Hoppmann N (2014) Detrimental effects of exuberant and restrained immune responses against the central nervous system in the context of multiple sclerosis and glioblastoma multiforme (Doctoral dissertation, Universitätsbibliothek Mainz).

Trentini A, Castellazzi M, Cervellati C, Manfrinato MC, Tamborino C, et al. (2016) “Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients,” Disease Markers pp. 1–9.

Fischer HJ, Sie C, Schumann E, Witte AK, Dressel R, et al. (2017) The Insulin Receptor Plays a Critical Role in T Cell Function and Adaptive Immunity. The Journal of Immunology 198:1910-1920.

Passos GR, Sato DK, Becker J, Fujihara K (2016) Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators of inflammation.